Keywords: Eisai, Halaven, Fycompa, Regulatory filing, South Africa, Breast caner, Epilepsy

Eisai expands in South Africa, filing for approval of Halaven and Fycompa

Article | 30 January 2013

Print This

Japanese drug major Eisai (TYO: 4523) says it is expanding its operations into South Africa, with the filing of its two ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in